These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17672812)

  • 1. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of time and practice resources required to provide weekly or monthly erythropoiesis-stimulating protein therapy to chronic kidney disease patients in the physician office setting.
    Bernardo M; Crawford P; Hertel J; Sholer C; Xu X; Goss T; Kewalramani R; Globe D
    J Manag Care Pharm; 2006; 12(9):714-25. PubMed ID: 17249904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Prescription-Assistance Program for Medically Uninsured Patients With Cancer: Case Study of a Public Hospital Experience in New York State.
    Gao L; Joseph J; Santoro-Levy M; Gotlieb VK; Multz AS
    J Oncol Pract; 2014 Mar; 10(2):104. PubMed ID: 29452556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
    Brouwer E; Yeung K; Barthold D; Hansen R
    J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Prescription Assistance Programs After the Affordable Health Care Act.
    Khan G; Karabon P; Lerchenfeldt S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):247-251. PubMed ID: 29485949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.
    Lee JJ; Sack DE; Kam S; Reed SC; Carew B; Lloyd C; Weaver EO; Miller RF
    J Community Health; 2023 Dec; 48(6):919-925. PubMed ID: 37284916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Patient Financial Assistance Programs in Reducing Costs for Cancer Patients.
    Zullig LL; Wolf S; Vlastelica L; Shankaran V; Zafar SY
    J Manag Care Spec Pharm; 2017 Apr; 23(4):407-411. PubMed ID: 28345445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical manufacturer assistance programs.
    Chisholm MA; DiPiro JT
    Arch Intern Med; 2002 Apr; 162(7):780-4. PubMed ID: 11926851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization.
    Burley MH; Daratha KB; Tuttle K; White JR; Wilson M; Armstrong K; McPherson S; Selinger S
    J Manag Care Spec Pharm; 2016 Apr; 22(4):381-7. PubMed ID: 27023691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between medication supplies and healthcare costs in older adults from an urban healthcare system.
    Stroupe KT; Murray MD; Stump TE; Callahan CM
    J Am Geriatr Soc; 2000 Jul; 48(7):760-8. PubMed ID: 10894314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic.
    Sarrafizadeh M; Waite NM; Hobson EH; Migden H
    Am J Health Syst Pharm; 2004 Sep; 61(17):1816-20. PubMed ID: 15462253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Program for procurement of drugs for indigent patients.
    Decane BE; Chapman J
    Am J Hosp Pharm; 1994 Mar; 51(5):669-71. PubMed ID: 8203387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a patient medication assistance program in a community pharmacy setting.
    Mounts VL; Ringenberg DG; Rhees K; Partridge C
    J Am Pharm Assoc (2003); 2005; 45(1):76-81. PubMed ID: 15730120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.
    Gellad WF; Huskamp HA; Li A; Zhang Y; Safran DG; Donohue JM
    J Gen Intern Med; 2011 Dec; 26(12):1458-64. PubMed ID: 21751052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
    Stebbins MR; Kaufman DJ; Lipton HL
    J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demystifying pharmaceutical patient assistance programs.
    Collier EK; Price KN; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Feb; 33(1):336-341. PubMed ID: 32308069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical office survival. Activity based costing for physicians.
    Greger RE
    Md Med; 2000; 1(3):24-6. PubMed ID: 10941243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.